Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Veracyte (VCYT) Operating Income: 2011-2024

Historic Operating Income for Veracyte (VCYT) over the last 14 years, with Dec 2024 value amounting to $16.1 million.

  • Veracyte's Operating Income rose 90.95% to $22.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.8 million, marking a year-over-year increase of 205.17%. This contributed to the annual value of $16.1 million for FY2024, which is 118.81% up from last year.
  • As of FY2024, Veracyte's Operating Income stood at $16.1 million, which was up 118.81% from -$85.8 million recorded in FY2023.
  • Over the past 5 years, Veracyte's Operating Income peaked at $16.1 million during FY2024, and registered a low of -$85.8 million during FY2023.
  • In the last 3 years, Veracyte's Operating Income had a median value of -$41.1 million in 2022 and averaged -$36.9 million.
  • In the last 5 years, Veracyte's Operating Income slumped by 133.95% in 2020 and then surged by 118.81% in 2024.
  • Over the past 5 years, Veracyte's Operating Income (Yearly) stood at -$35.4 million in 2020, then slumped by 131.44% to -$81.9 million in 2021, then spiked by 49.84% to -$41.1 million in 2022, then slumped by 108.84% to -$85.8 million in 2023, then skyrocketed by 118.81% to $16.1 million in 2024.